Delivery Order SPE2DB24D1205-SPE2DB24FCUXR

Award Date 9/20/24
Potential Completion Date 9/23/24
Potential Value $23K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to supply TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a prescription medication. The award, valued at $2,902.80, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, potentially worth up to $999,999,999 through December 2025. This IDC enables DLA to efficiently procure a range of essential pharmaceutical and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to supply TRULICITY 3 MG/0.5 ML PEN 0.5ML, a prescription medication. The Firm Fixed Price delivery order has a ceiling value of $1,741.68 and an ultimate completion date of July 30, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued at up to $999,999,999...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $31,568.19 Firm Fixed Price delivery order is for the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a prescription medication. The contract has an ultimate completion date of August 13, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025 between Amerisourcebergen and the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,306.26 and a completion date of August 5, 2024. This award is a task order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at up to $999,999,999 through...
This is a federal contract award with the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML. The contract has a ceiling value of $2,841.84 and is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025. This IDC enables the DLA to efficiently procure a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,886.82 delivery order is for the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a prescription medication. The contract has a firm fixed price and an ultimate completion date of October 11, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, with a ceiling value of $1,402.24, is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a diabetes medication. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a prescription medication. The contract has a ceiling value of $3,175.12 and a completion date of May 21, 2024. It was awarded by the Defense Logistics Agency (DLA), a defense agency, on a Firm Fixed Price basis. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a prescription medication. The firm-fixed-price delivery order has a ceiling value of $2,902.80 and an ultimate completion date of August 21, 2024. This contract is not set aside for a specific business type. Amerisourcebergen, through its Corporate Office Division, has been awarded numerous federal...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of TRULICITY 3 MG/0.5 ML PEN 0.5ML. The contract has a ceiling value of $1,741.68 and an ultimate completion date of August 27, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive...
  • SPE2DB24D1205
    Indefinite Delivery Contract
  • SPE2DB24D1205-SPE2DB24FCUXR
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML. The contract has a ceiling value of $22,734.74 and a completion date of September 23, 2024. It is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables DLA Troop Support Medical to efficiently procure a comprehensive range of medical commodities, including pharmaceutical products, to support military treatment programs and facilities worldwide. This contract does not have a set-aside designation.

Generated 12/20/24, 9:04 AM